title: Conversion to Neoral for tacrolimus-related adverse effects in liver transplant recipients and improvement in quality of life.
authors.affiliation: Division of Surgical Research, Department of Surgery, University of Bonn, Bonn, Germany.
authors.forename: R H
authors.initials: RH
authors.lastname: Tolba
authors.forename: B
authors.initials: B
authors.lastname: Wrigge
authors.forename: U
authors.initials: U
authors.lastname: Machein
authors.forename: T
authors.initials: T
authors.lastname: Minor
authors.forename: J C
authors.initials: JC
authors.lastname: Kalff
authors.forename: A
authors.initials: A
authors.lastname: Hirner
authors.forename: M
authors.initials: M
authors.lastname: Wolff
mesh_terms: D000328:Adult; D016572:Cyclosporine / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D004644:Emotions; D005260:Female; D006304:Health Status; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000627:therapeutic use; D007668:Kidney / Q000187:drug effects / Q000473:pathology*; D016031:Liver Transplantation / Q000502:physiology* / Q000523:psychology*; D008297:Male; D008603:Mental Health; D008775:Methylprednisolone / Q000627:therapeutic use; D008875:Middle Aged; D010146:Pain; D011788:Quality of Life; D016559:Tacrolimus / Q000009:adverse effects* / Q000097:blood
chemical_list: D007166:Immunosuppressive Agents; D016572:Cyclosporine; D016559:Tacrolimus; D008775:Methylprednisolone